维普中文期刊产品整合服务
208篇 您的检索式:作者名="Robak T"
    题名 作者 年代 出处 被引量
1Monoclonal antibodies in the treatment of systemic lupus erythematosus显示文摘Robak E Robak T 2009Curt Drug Targets2009,10,1:1
2Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia显示文摘Robak T Dmoszynska A Solal-Céligny P 2010J Clin Oncol2010,28,10:1
3Synthesis and applications of tert-butanesunamide 显示文摘Robak M T Herbage M A Ellman J A 2010Chem Rev2010,110,6:1
4Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma显示文摘Robak T Huang H Jin J 2015N Engl J Med2015,372,10:1
5Older and new purine nucleoside analogs for patients with acute leukemias显示文摘Robak P Robak T 2013Cancer Treat Rev2013,39,8:1
6显示文摘Robak T Blonski JZ Kasznicki M 2000Blood2000,96,:1
7Pharmacogenomics of MDR1/ABCB1gene : the influence on risk and clinical outcome ofhaematological malignancies显示文摘Jamroziak K Robak T 2004Hematology2004,9,2:1
8The mammalian target of the rapamycin(mTOR) kinase pathway: its role in tumourigenesis and targeted antitumour therapy 显示文摘JANUS A ROBAK T SMOLEWSKI P 2005Cell Mol Biol Lett2005,10,:1
9Older and new purine nucleoside analogs for patients with acute leukemias显示文摘Robak P Robak T 2013Cancer Treat Rev2013,39,8:1
10Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR- ABL-positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG) 显示文摘Wrzesiefi-Ku: A Robak T Pluta A 2006Ann Hematol2006,85,6:1
11A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG)显示文摘Wrzesiefi-Ku~ A Robak T Lech-Marafida E 2003Eur J Haematol2003,71,3:1
12Outcome of treatment in adults with philadelphia chromosome - positive and/or BCR - ABL - positive acute lymphoblastic leukemia - retrospective analysis of polish adult leukemia group (PALG) 显示文摘Wrzesien- Kus A Robak T Pluta A 2006Ann Hematol2006,85,6:1
13Current and emerging therapies for acute myeloid leukemia 显示文摘Robak T Wierzhowska A 2009Clin Ther2009,2,:1
14International multicenter Phase Ⅱ study of the HDAC inhibitor(HDACi)depsipeptide(FK228) in cutaneous T-cell lymphoma (CTCL):Interim report显示文摘Whittaker S Mcculloch W Robak T 2006Clin Oncol2006,24,18:1
15Biological properties and therapeutic use of interleukin 2 (IL-2)显示文摘ROBAK T 1995Advances in Hygiene and Experimental Medicine1995,49,3:1
16Enantioseleetive aza -henry reaction with an N - sultinyl urea organocatalyst 显示文摘Robak M T Trineado M EUman J A 2007J Am Chem Soc2007,129,15:1
17Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first line therapy for chronic lymphocytic leukemia:a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study)显示文摘Robak T Jamroziak K Gora-Tybor J 2010J Clin Oncol2010,28,10:1
18Cladribine alone and in combination with cyclophos-phamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of prospective, multi-center, randomized trial of the Polish Adult Leukemia Group (PALG CLL2)显示文摘Robak T Blonski JZ Gora-Tybor J 2006Blood2006,108,:1
19Rozrolimupab,a mixture of25 recombinant human monoclonal Rh D antibodies,in the treatment of primary immune thrombocytopenia显示文摘Robak T Windyga J Trelinski J 2012Blood2012,120,18:1
20Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma显示文摘Robak T Huang H Jin J 2015N Engl J Med2015,372,:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费